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Abstract 
Dietary fat is considered central to the management of obesity and heart disease risk, and more recently 
with the risk of type 2 diabetes, given its observed role in the development of insulin resistance in 
mechanistic studies. For changes in lipid profiles, foods delivering substantial amounts of 
polyunsaturated fatty acids relative to saturated fats are of interest, and walnuts fit this category.As a 
class of foods, nuts have been shown to provide benefits to health in a number of clinical trials. A review 
of the cardiovascular benefits of nuts indicated their value on thrombotic factors, inflammatory markers 
and endothelial function.Including 30g walnuts per day in a dietary advice scheme that related to all major 
food groups resulted in beneficial lipid profiles for adults with early type 2 diabetes mellitus. Walnuts 
should be ‘prescribed’ to adults with type 2 diabetes mellitus In clinical practice prescribing walnuts 
assists the clinician in giving more detailed dietary advice that is likely to be on target for the desired 
outcomes. The reality for ‘free living’ conditions is that foods such as walnuts may need to be considered 
core foods in these treatment strategies, as they help to ‘take the guesswork’ out of ensuring adequate 
intakes of polyunsaturated fats. 
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Executive Summary 1
Dietary fat and diabetes 2
• Dietary fat is considered central to the management of obesity and heart disease risk, and more 3
recently with the risk of type 2 diabetes, given its observed role in the development of insulin 4
resistance in mechanistic studies. 5
• For changes in lipid profiles, foods delivering substantial amounts of polyunsaturated fatty acids 6
relative to saturated fats are of interest, and walnuts fit this category. 7
Nutritional composition of walnuts 8
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Walnut 2901 69.2 4.4 12.1 49.4 6260 
Pistachio 2530 50.6 5.8 26.6 15.8 0 
Pine Nut 2921 70.0 4.2 23.0 39.8 0 
Pecan 2977 71.9 4.5 39.1 24.8 620 
Macadamia 3068 76.2 10.3 61.4 0.9 0 
Hazelnut 2693 61.4 2.7 48.6 7.1 120 
Cashew 2437 49.2 8.4 31.1 7.5 0 
Brazil 2888 68.5 14.8 21.8 29.0 0 
Almond 2525 55.2 3.6 36 13.1 0 
Benefits of walnuts 9
• As a class of foods, nuts have been shown to provide benefits to health in a number of clinical trials. 10
• A review of the cardiovascular benefits of nuts indicated their value on thrombotic factors, 11
inflammatory markers and endothelial function. 12
Walnuts in the context of the whole diet 13
• Including 30g walnuts per day in a dietary advice scheme that related to all major food groups 14
resulted in beneficial lipid profiles for adults with early type 2 diabetes mellitus. 15
Walnuts should be ‘prescribed’ to adults with type 2 diabetes mellitus 16
• In clinical practice prescribing walnuts assists the clinician in giving more detailed dietary advice 17
that is likely to be on target for the desired outcomes.   18
• The reality for ‘free living’ conditions is that foods such as walnuts may need to be considered core 1
foods in these treatment strategies, as they help to ‘take the guesswork’ out of ensuring adequate 2
intakes of polyunsaturated fats.   3
4
Introduction 1
Walnuts are a high fat food, but they deliver desirable fats in a food matrix favourable to the prevention 2
and management of type 2 diabetes mellitus.  In the first instance, significance of walnut fatty acids is 3
perhaps best viewed in the context of heart disease risk associated with diabetes.   4
The link between diet and the risk of coronary heart disease has been known for decades, beginning 5
with the early observation by Keys and colleagues of higher rates of heart disease in populations with 6
higher consumption of saturated fatty acids [1].  Since that time the knowledge base has expanded 7
substantially through research from a number of disciplines.  Cellular and animal model studies have 8
provided explanations of possible mechanisms, epidemiological research has established relationships 9
between dietary variables and risk factors, and clinical trials have demonstrated the effects of dietary 10
intervention.  Further, observations of pathological and treatment commonalities between type 2 11
diabetes, obesity and coronary heart disease have been described through the concept of metabolic 12
syndrome [2].   13
Dietary fat is considered central to the management of obesity and heart disease risk, and more recently 14
with the risk of type 2 diabetes, given its observed role in the development of insulin resistance in 15
mechanistic studies [3].  A recent review of human research has argued how the type of fat may be 16
linked to the development of diabetes, with studies showing that replacing saturated and trans fats with 17
unsaturated fats, and including nuts in the diet may help to prevent diabetes [4].   18
In the case of obesity, a low fat approach to diet has been promulgated, given the energy density of high 19
fat foods [5], and in cardiovascular disease the type of fat is addressed, given the differential effects of 20
fatty acids on blood lipids [6].  While much of the focus of dietary treatment in diabetes has been on 21
blood glucose control, and thereby dietary carbohydrate, a number of studies in patients with metabolic 22
syndrome have proven the effects of manipulating the type of fat in improving insulin sensitivity [7].  A 23
further reason for addressing dietary fat in the diabetic population has been the recognised need to treat 24
dyslipidemia, given the higher risk of cardiovascular disease in this disease group [6, 8]. 25
Translating theory to practice, however, remains a challenge, especially as advice should relate to foods 26
not nutrients.  The nutrient composition of foods provides some guidance, but further evidence is 27
required on the impact of targeted foods on changing biomarkers of risk.  For changes in lipid profiles, 28
foods delivering substantial amounts of polyunsaturated fatty acids relative to saturated fats are of 29
interest, and walnuts fit this category.  This review examines the position of walnuts in the diet for the 30
prevention and management of type 2 diabetes mellitus.  First, the nutritional profile of walnuts is 31
argued as favourable for the disease state and evidence of their benefits is cited from the literature.  32
Finally, it is emphasised that the means by which walnuts deliver benefits is dependent on their position 1
in the whole diet, bearing in mind the patient’s overall nutritional requirements and need for energy 2
balance. 3
Nutritional composition of walnuts 4
Like all natural foods, walnuts have a distinct composition.  Most notably, they contain substantial 5
amounts of both n-6 and n-3 fatty acids, the latter in the form of α-linolenic acid.  This differentiates 6
walnuts from other nuts, bearing in mind that as a group, nuts deliver unsaturated fatty acids (Table 1).  7
Both n-6 and n-3 fatty acids are limited in the diet, but n-3 even more so, and there is argument that the 8
balance between n-3 and n-6 fatty acids is an important consideration in disease risk management [9]. 9
Table 1 Nutritional analysis of tree nutsa10 
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Walnut 2901 69.2 4.4 12.1 49.4 6260 
Pistachio 2530 50.6 5.8 26.6 15.8 0 
Pine Nut 2921 70.0 4.2 23.0 39.8 0 
Pecan 2977 71.9 4.5 39.1 24.8 620 
Macadamia 3068 76.2 10.3 61.4 0.9 0 
Hazelnut 2693 61.4 2.7 48.6 7.1 120 
Cashew 2437 49.2 8.4 31.1 7.5 0 
Brazil 2888 68.5 14.8 21.8 29.0 0 
Almond 2525 55.2 3.6 36 13.1 0 
a Foodworks nutrient analysis software package, AusNut Database, Xyris software, Highgate Hill, Brisbane Australia 3.2, 2002.  11 
b Foodworks nutrient analysis software package, Fatty Acid Database, Xyris software, Highgate Hill, Brisbane Australia 3.2, 2002. 12 
In addition to fatty acids, the walnut food matrix also includes protein (rich in arginine), fibre, and anti-13
oxidants, largely in the form of γ tocopherol and various polyphenolic compounds.  Recent research has 14
found a link between arginine intake and lower levels of a biomarker of heart disease, C-reactive 15
protein [10].  Another study has found potential benefits of arginine in weight loss [11].  The arginine-16
rich protein and natural fibre components of walnuts may have benefits in themselves, bearing in mind 17
that both protein and fibre play a role in appetite control.   18
Given the unsaturated fat content of walnuts, however, the presence of anti-oxidants is an important 19
consideration.  While foods containing polyunsaturated fats may be seen as desirable, supplemental 20
studies indicate that the oxidative stability of plasma and LDL may be at risk with the delivery of high 21
levels of unsaturated fatty acids [12].  There is evidence that oxidative stress plays a role in 1
atherogenesis, and that γ tocopherol may have protective functions [13].  Polyphenolics in walnuts have 2
been found to act as effective inhibitors of in vitro plasma and LDL oxidation [14].  More recent animal 3
model research has extended this view, showing oxidative stress to be reduced in mice supplemented 4
for 4 weeks with a polyphenol-rich walnut extract [15]. While research on bioactive ingredients in food 5
is necessarily reductionist, there is something to be said for the benefits of the whole food matrix via 6
the synergies that are created from the combination of nutrients.  This may partly explain the apparent 7
anomalies in recent vitamin supplementation trials where nil benefits were found on CVD risk [16, 17], 8
despite positive correlations between health outcomes and the intake of foods such as vegetables and 9
fruits delivering these vitamins [18].   10
For all of these reasons, the nutritional profile of walnuts clearly suits the dietary needs of patients with 11
type 2 diabetes mellitus. 12
Benefits of walnuts 13
As a class of foods, nuts have been shown to provide benefits to health in a number of clinical trials. 14
Given the higher unsaturated fat content of nuts, this outcome would be expected under conditions 15
where the P:S ratio of the whole diet was favourable.  It is also shown in studies where patients 16
consumed nuts on a daily basis.  Outcomes in hypercholesterolemic patients included reduced total 17
and/or LDL-cholesterol concentrations [19-21],  and changes to lipid distribution among lipoprotein 18
sub-classes with walnuts [22].  Not surprisingly, given the links between dietary fats and insulin 19
resistance, analyses from cohort studies have suggested reduced risk of type 2 diabetes mellitus in 20
women with higher nut consumption [23].   21
Given the high energy density of nuts, however, energy balance may be an issue in those wishing to 22
lose weight.  One review found inclusion of nuts in the diet did not result in body weight change in 12 23
of the 13 trials reporting body weight change [24].  A more recent review argued that the continued 24
observation of no weight gain with inclusion of nuts (even in the context of apparent increased energy 25
intake) may be due to inefficient absorption, increased energy expenditure, and increased satiety [25].  26
This again, points to the whole food matrix as being a significant dietary consideration.  In a recent 27
study of patients with type 2 diabetes mellitus, percent body fat remained below the baseline 28
measurement with the diet inclusive of walnuts compared to standard clinical practice [26], a finding 29
that warrants further investigation with greater numbers of subjects. 30
A review of the cardiovascular benefits of nuts indicated their value on thrombotic factors, 31
inflammatory markers and endothelial function [27].  Walnuts were singled out as associated with 32
reduced total cholesterol, LDL, triacylglcerol, and LDL:HDL ratios, as well as improved brachial artery 1
reactivity and reduced levels of vascular cell adhesion molecule-1.   2
While the favourable fatty acid profile of nuts would explain cardiovascular benefits, the differences 3
seen between studies involving nuts may be due to differences in overall composition.  It may also 4
reflect the extent of detail in the attention paid to overall diet in the research design.  An extensive 5
review of the scientific evidence for the beneficial health relationship between walnuts and coronary 6
heart disease conducted in 2002 found lowered blood cholesterol concentrations in heart health 7
promoting diets containing walnuts [28].  The limitations of the research to date related to the length of 8
time of the studies and the need for research more reflective of ‘real life’ contexts.  The latter is a 9
problem for randomised controlled trial (RCT) methodology, but in dietary trials especially, the closer 10
the study can match free living conditions the closer the evidence will lie to efficacy in clinical practice. 11
Walnuts in the context of the whole diet 12
Current practice guidelines recommend the inclusion of food sources of nutrients targeted as beneficial 13
in the treatment of diabetes and heart disease in particular. [20, 29-32].  To meet dietary targets for 14
nutritional adequacy a variety of core foods is required; to meet targets of macronutrient proportions, 15
specific foods need to be emphasised because of their unique value and attributes. For example, 16
American Heart Association recommends including unsaturated fatty acids from fish, vegetables, 17
legumes and nuts in order to achieve a healthy diet [6].  18
Including 30g walnuts per day in a dietary advice scheme that related to all major food groups resulted 19
in beneficial lipid profiles for adults with early type 2 diabetes mellitus [26].  This study demonstrated 20
the way in which walnuts needed to be located in the overall diet by exposing a dietary modelling 21
process whereby other foods in the diet were encouraged or delimited [33].  The beneficial effects were 22
no doubt due largely to the dietary fatty acid profile of the overall diet, but clearly the inclusion of the 23
walnuts enabled that to happen much more effectively than standard clinical practice or even a more 24
detailed advice scheme that nevertheless did not name specific foods.  This is the way in which whole 25
foods can exert their effects.  The clinical outcome is not a single food effect, but the positioning of 26
single foods delivering significant and important nutrients makes all the difference.  In another study of 27
hypercholesterolemic men and women emphasising walnuts in a Mediterranean diet (over other 28
monounsaturated fat rich foods) resulted in greater improvement in endothelium dependent 29
vasodilation and greater reductions in levels of vascular cell adhesion molecule – 1 compared to the 30
standard Mediterranean diet.  Reductions in cholesterol were correlated with increased dietary ALA and 31
LDL γ tocopherol levels, both reflecting walnut composition [34]. Again this demonstrates the impact 32
of positioning walnuts in the context of the whole diet. 33
In clinical practice prescribing walnuts assists the clinician in giving more detailed dietary advice that 1
is likely to be on target for the desired outcomes.  The reality for ‘free living’ conditions is that foods 2
such as walnuts may need to be considered core foods in these treatment strategies, as they help to ‘take 3
the guesswork’ out of ensuring adequate intakes of polyunsaturated fats, in addition to the other 4
benefits they bring as whole foods.  Other foods such as fish and dairy foods may have the same role to 5
play, and their attributes may be demonstrated in a similar fashion.  As knowledge of the composition 6
of whole foods and their unique attributes increases there are implications for the improved formulation 7
of manufactured foods, in particular snacks.  While it is unlikely that whole foods will play a role in 8
therapeutics, their real significance in the prevention and management of risk factors for lifestyle 9
disease is clearly unfolding.10
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